Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Diabetes. Jul 15, 2023; 14(7): 1091-1102
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1091
Table 1 Quality-of-care scoring system
Item
Score
HbA1c
    HbA1c measurement < 2/yr & HbA1c ≥ 8% (64 mmol/mol)0
    HbA1c measurement < 2/yr & HbA1c < 8% (64 mmol/mol)1
    HbA1c measurement ≥ 2/yr & HbA1c ≥ 8% (64 mmol/mol)1
    HbA1c measurement ≥ 2/yr & HbA1c < 8% (64 mmol/mol)2
Blood pressure
    Co-morbidity of hypertension, never used anti- hypertension agents0
    SBP ≥ 130 mmHg or DBP ≥ 80 mmHg, never used anti-hypertension agents0
    No blood pressure data, ever used anti-hypertension agents0
    SBP ≥ 130 mmHg or DBP ≥ 80 mmHg, ever used anti-hypertension agents0
    No blood pressure data, no co-morbidity of hypertension, and never used anti-hypertension agents1
    SBP < 130 mmHg and DBP < 80 mmHg1
Lipid profile
    Lipid profile measurement < 1/yr & LDL cholesterol ≥ 1000
    Lipid profile measurement < 1/yr & LDL cholesterol < 1001
    Lipid profile measurement ≥ 1/yr & LDL cholesterol ≥ 100 1
    Lipid profile measurement ≥ 1/yr & LDL cholesterol < 1002
Eye exam
    Eye measurement < 1/yr0
    Eye measurement ≥ 1/yr1
Foot exam
    Foot exam < 1/yr0
    Foot exam ≥ 1/yr1
Urine exam
    Urine exam < 1/yr0
    Urine exam ≥ 1/yr1